111 related articles for article (PubMed ID: 11523117)
1. [Gelsolin gene therapy using adenovirus vector for orthotopically implanted human urinary bladder carcinoma in nude mice].
Sazawa A
Hokkaido Igaku Zasshi; 2001 Jul; 76(4):263-71. PubMed ID: 11523117
[No Abstract] [Full Text] [Related]
2. Gelsolin gene therapy by retrovirus producer cells for human bladder cancer in nude mice.
Tanaka M; Sazawa A; Shinohara N; Kobayashi Y; Fujioka Y; Koyanagi T; Kuzumaki N
Cancer Gene Ther; 1999; 6(5):482-7. PubMed ID: 10505859
[TBL] [Abstract][Full Text] [Related]
3. [Tumor suppressive function of gelsolin].
Kuzumaki N; Tanaka M; Sakai N; Fujita H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1436-41. PubMed ID: 9309138
[TBL] [Abstract][Full Text] [Related]
4. An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies.
Watanabe T; Shinohara N; Sazawa A; Harabayashi T; Ogiso Y; Koyanagi T; Takiguchi M; Hashimoto A; Kuzumaki N; Yamashita M; Tanaka M; Grossman HB; Benedict WF
Cancer Gene Ther; 2000 Dec; 7(12):1575-80. PubMed ID: 11228536
[TBL] [Abstract][Full Text] [Related]
5. [Adenovirus-mediated double suicide gene therapy for experimental bladder carcinoma].
Tan WL; Xie Y; Wu YD; Zhu WH; Zheng SB
Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):594-7. PubMed ID: 16762858
[TBL] [Abstract][Full Text] [Related]
6. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
Loskog A; Tötterman TH; Böhle A; Brandau S
Cancer Gene Ther; 2002 Oct; 9(10):846-53. PubMed ID: 12224026
[TBL] [Abstract][Full Text] [Related]
7. Enhanced tumor suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein.
Xu HJ; Zhou Y; Seigne J; Perng GS; Mixon M; Zhang C; Li J; Benedict WF; Hu SX
Cancer Res; 1996 May; 56(10):2245-9. PubMed ID: 8625292
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
Izawa JI; Sweeney P; Perrotte P; Kedar D; Dong Z; Slaton JW; Karashima T; Inoue K; Benedict WF; Dinney CP
Clin Cancer Res; 2002 Apr; 8(4):1258-70. PubMed ID: 11948141
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus mediated gelsolin gene therapy for orthotopic human bladder cancer in nude mice.
Sazawa A; Watanabe T; Tanaka M; Haga K; Fujita H; Harabayashi T; Shinohara N; Koyanagi T; Kuzumaki N
J Urol; 2002 Sep; 168(3):1182-7. PubMed ID: 12187264
[TBL] [Abstract][Full Text] [Related]
10. Cloning and analysis of human UroplakinII promoter and its application for gene therapy in bladder cancer.
Zhu HJ; Zhang ZQ; Zeng XF; Wei SS; Zhang ZW; Guo YL
Cancer Gene Ther; 2004 Apr; 11(4):263-72. PubMed ID: 14963492
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated expression of dominant negative c-myb induces apoptosis in head and neck cancer cells and inhibits tumor growth in animal model.
Kim SY; Yang YS; Hong KH; Jang KY; Chung MJ; Lee DY; Lee JC; Yi HK; Nam SY; Hwang PH
Oral Oncol; 2008 Apr; 44(4):383-92. PubMed ID: 17690006
[TBL] [Abstract][Full Text] [Related]
12. Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model.
Kleinerman DI; Dinney CP; Zhang WW; Lin SH; Van NT; Hsieh JT
Cancer Res; 1996 Aug; 56(15):3431-5. PubMed ID: 8758907
[TBL] [Abstract][Full Text] [Related]
13. Growth inhibition efficacy of an adenovirus expressing dual therapeutic genes, wild-type p53, and anti-erbB2 ribozyme, against human bladder cancer cells.
Irie A; Matsumoto K; Anderegg B; Kuruma H; Kashani-Sabet M; Scanlon KJ; Uchida T; Baba S
Cancer Gene Ther; 2006 Mar; 13(3):298-305. PubMed ID: 16110311
[TBL] [Abstract][Full Text] [Related]
14. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
[TBL] [Abstract][Full Text] [Related]
15. Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme.
Feng M; Cabrera G; Deshane J; Scanlon KJ; Curiel DT
Cancer Res; 1995 May; 55(10):2024-8. PubMed ID: 7743496
[TBL] [Abstract][Full Text] [Related]
16. A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells.
Shirakawa T; Hamada K; Zhang Z; Okada H; Tagawa M; Kamidono S; Kawabata M; Gotoh A
Clin Cancer Res; 2004 Jul; 10(13):4342-8. PubMed ID: 15240520
[TBL] [Abstract][Full Text] [Related]
17. Bladder cancer therapy using combined proliferating cell nuclear antigen antisense oligonucleotides and recombinant adenovirus p53.
Zhu Z; Xing S; Lin C; Zhang X; Fu M; Liang X; Zeng F; Lu G; Wu M
Chin Med J (Engl); 2003 Dec; 116(12):1860-3. PubMed ID: 14687474
[TBL] [Abstract][Full Text] [Related]
18. Intra-arterial adenoviral mediated tumor transfection in a novel model of cancer gene therapy.
Cabrera G; Porvasnik SL; DiCorleto PE; Siemionow M; Goldman CK
Mol Cancer; 2006 Aug; 5():32. PubMed ID: 16899125
[TBL] [Abstract][Full Text] [Related]
19. Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice.
Yoon SK; Armentano D; Wands JR; Mohr L
Cancer Gene Ther; 2001 Aug; 8(8):573-9. PubMed ID: 11571535
[TBL] [Abstract][Full Text] [Related]
20. A 'bioreactor' for bladder cancer cells.
Foubister V
Drug Discov Today; 2004 Nov; 9(22):946-7. PubMed ID: 15539134
[No Abstract] [Full Text] [Related]
[Next] [New Search]
